During the last session, Jaguar Health Inc (NASDAQ:JAGX)’s traded shares were 34.1 million, with the beta value of the company hitting 1.11. The 52-week high for the JAGX share is $1.22, that puts it down -617.65 from that peak though still a striking 70.59% gain since the share price plummeted to a 52-week low of $0.05. The company’s market capitalization is $46.93M, and the average trade volume was 61.08 million shares over the past three months.
Jaguar Health Inc (NASDAQ:JAGX) trade information
Jaguar Health Inc (JAGX) registered a 1.13% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.13% in intraday trading to $0.17, hitting a weekly high. The stock’s 5-day price performance is 3.03%, and it has moved by 135.32% in 30 days. Based on these gigs, the overall price performance for the year is -69.50%.
Jaguar Health Inc (JAGX) estimates and forecasts
Statistics show that Jaguar Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Jaguar Health Inc (JAGX) shares have gone down -47.93% during the last six months, with a year-to-date growth rate more than the industry average at 77.65% against 10.10. In the rating firms’ projections, revenue will decrease -18.40% compared to the previous financial year.
Revenue for the current quarter is expected to be $2.3 million as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to $2.76 million by the end of Mar 2024. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $3.26 million .
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 86.10%.
JAGX Dividends
Jaguar Health Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
